Non-invasive hemostatic closure devices: "Patches and pads"

Techniques in Vascular and Interventional Radiology

Volumn 6, Issue 2, 2003, Pages 92-95

  Hirsch, Joshua A ^a   Reddy, Steve A ^b   Capasso, William E ^b   Linfante, Italo ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIOTOMY; ARTERY CATHETERIZATION; DEVICE; HEMOSTASIS; NONHUMAN; REVIEW;

EID: 0042591551     PISSN: 10892516     EISSN: None     Source Type: Journal    
DOI: 10.1053/tvir.2003.36446     Document Type: Article

References (16)

1. Toursarkissian B, Mejia A, Smilanach RP, et al: Changing pattern of access site complications with the use of percutaneous closure devices. Vasc Endovasc Surg 35:203-206, 2001
2. Johanning JM, Franklin DP, Elmore JR, et al: Femoral artery infections associated with percutaneous arterial closure devices. J Vasc Surg 34:983-985, 2001
3. Shrake KL: Comparison of major complication rates associated with four methods of arterial closure. Am J Cardiol 85:1024-1025, 2000
4. Ripkin W, Brophy C, Nesbit R, et al: Early experience with infectious complications of percutaneous femoral artery closure devices. J Vasc Surg 32:205-208, 2000
5. Chamberlin JR, Lardi AB, McKeever LS, et al: Use of vascular sealing devices vs. assisted manual compression in transcatheter coronary interventions requiring abciximab. Cathet Cardiovasc Intervent 47: 143-147, 1999
6. Applegate R, Grabarczyk MA, Little WC, et al: Vascular closure devices in patients treated with anticoagulation and IIb/IIIa receptor inhibitors during percutaneous revascularization. J Am Cardiol 40: 78-83, 2002
7. Dangas G, Mehran R, Kokolis S, et al: Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices. J Am Cardiol 38:638-644, 2001
8. Duffin D, Muhlestein JB, Allissan SB, et al: Femoral arterial puncture management after percutaneous coronary procedures: A comparison of clinical outcomes and patient satisfaction between manual compression and two different vascular closure devices. J Inv Cardiol 13:354-362, 2001
9. Nader R, Garcia JC, Drushal K, et al: Clinical evaluation of the SyvekPatch in consecutive patients undergoing interventional, EPS and diagnostic cardiac catheterization procedures. J Inv Cardiol 6:305-307, 2002
10. Cole DJ, Connolly RJ, Chan MW, et al: A pilot study evaluating the efficacy of a fully acetylated poly-N-acetyl glucosamine membrane formation as a topical hemostatic agent. Surgery 126:510-517, 1999
11. Vournakis J, Pariser ER, Finkielstein S, et al: U.S. Patent #5,623,064, Poly-N-acetyl glucosamine, issued April 22, 1997
12. Ikeda Y, Young LH, Vournakis JN, et al: Vascular effects of poly-N-acetylglucosime in isolated aortic rat rings. J Surg Res 102:215-220, 2002
13. Chan MW, Schwaitzberg SD, Demcheva M, et al: Comparison of poly-N-acetyl glucosamine with absorbable collagen (Actifoam), and fibrin sealant (Bolheal) for achieving hemostasis in a swine model of splenic hemorrhage. J Trauma 48:454-458, 2000
14. Meeting the challenges of heightened competition, rising costs and drug-eluting stents. Cardiovascular Roundtable, 2002 Briefing, The Advisory Board Company, Washington, DC
15. Resnic F, Blake GJ, Ohno-Machado L, et al: Vascular closure devices and the risk of vascular complications after percutaneous coronary interventions in patients receiving glycoprotein IIb/IIIa inhibitors. Am J Cardiol 88:493-496, 2001
16. Carney D, Martin JR, Moore CA, et al: Complications of femoral artery closure devices. Cathet Cardiovasc 52:3-7, 2001